Enhancing Juvenile Drug Court Outcomes With Evidence-Based Practices

Adolescent Substance Use Clinical Trial

Official title:

Enhancing Juvenile Drug Court Outcomes With Evidence-Based Practices

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01266109
• Other study ID #: 019892
• Secondary ID: R01DA019892
• Status: Completed
• Phase: Phase 2
• First received: November 18, 2010
• Last updated: June 17, 2013
• Start date: September 2007
• Est. completion date: March 2012

Study information

• Verified date: May 2013
• Source: Medical University of South Carolina
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Juvenile drug courts were developed in response to a perceived need to intervene more effectively with youth with substance abuse problems. Close collaboration between the court and substance abuse treatment provider is a defining component of the drug court model and is critical to helping youth achieve positive outcomes. Despite the proliferation of juvenile drug courts in recent years, however, evaluation of their capacity to reduce offender substance use and criminal activity has lagged. Moreover, the Institute of Medicine (IOM, 1998) and leading experts (McLellan, Carise, & Kleber, 2003) have presented a bleak picture of the nation's capacity to meet the treatment needs of substance abusing individuals. Although community-based programs provide the backbone of substance abuse treatment in the nation, their capabilities have not kept up with major scientific advances in the development and validation of evidence-based substance abuse interventions.

Building on our research findings and experience regarding juvenile drug court outcomes as well as the transport of evidence-based practices to community treatment settings, the purpose of this study is to develop and test a relatively flexible and low cost strategy for enhancing the outcomes of juvenile drug courts by integrating components of evidence-based treatments into existing substance abuse services.

Specifically, this project aims to:

Aim 1: Adapt existing intervention and training protocols from evidence-based practices (i.e., Contingency Management for adolescent substance abuse; family engagement strategies from evidence-based treatments of juvenile offenders) for integration into juvenile drug court sites.

Aim 2: Conduct a study to examine youth (e.g., substance use and criminal behavior) and system level (e.g., intervention adherence, feasibility, retention and completion rates, consumer satisfaction, cost estimates) effects of implementing the intervention protocols in juvenile drug courts.

Aim 3: Revise the intervention and training protocols in preparation for a Stage II study if findings are supportive.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 172
• Est. completion date: March 2012
• Est. primary completion date: March 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 12 Years to 17 Years

Eligibility

Inclusion Criteria:

• Juvenile Drug Court-involved youth

• Fluency in English

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Adolescent Substance Use

Intervention

Behavioral:
• Contingency Management-Family Engagement (CM-FAM)
Evidence-based outpatient intervention for adolescent substance use

Other:
• Usual Services (US)
Typical community-based substance abuse treatment services

Locations

Country	Name	City	State
United States	Medical University of South Carolina	Charleston	South Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Medical University of South Carolina	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Henggeler SW, McCart MR, Cunningham PB, Chapman JE. Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices. J Consult Clin Psychol. 2012 Apr;80(2):264-75. doi: 10.1037/a0027147. Epub 2012 Feb 6. — View Citation

McCart MR, Henggeler SW, Chapman JE, Cunningham PB. System-level effects of integrating a promising treatment into juvenile drug courts. J Subst Abuse Treat. 2012 Sep;43(2):231-43. doi: 10.1016/j.jsat.2011.10.030. Epub 2011 Dec 5. — View Citation

Tuerk EH, McCart MR, Henggeler SW. Collaboration in family therapy. J Clin Psychol. 2012 Feb;68(2):168-78. doi: 10.1002/jclp.21833. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Substance Use		Quarterly for up to 1 year post-baseline	No
Secondary	Delinquency		Quarterly for up to 1 year post-baseline	No
Secondary	Intervention Fidelity		Monthly for up to 1 year post-baseline	No
Secondary	Cost Estimates		Annually for 4 years	No
Secondary	Consumer Satisfaction		Bi-annually for 4 years	No

External Links

•   Family Services Research Center Webpage